| Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis T Chitnis, C Gonzalez, BC Healy, S Saxena, M Rosso, C Barro, ... Annals of clinical and translational neurology 5 (12), 1478-1491, 2018 | 139 | 2018 |
| Association between cigarette smoking and multiple sclerosis: a review M Rosso, T Chitnis JAMA neurology 77 (2), 245-253, 2020 | 104 | 2020 |
| Down syndrome disintegrative disorder: a clinical regression syndrome of increasing importance M Rosso, E Fremion, SL Santoro, NM Oreskovic, T Chitnis, BG Skotko, ... Pediatrics 145 (6), 2020 | 46 | 2020 |
| Neurologic complications of Down syndrome: a systematic review JD Santoro, D Pagarkar, DT Chu, M Rosso, KC Paulsen, P Levitt, MS Rafii Journal of Neurology 268, 4495-4509, 2021 | 40 | 2021 |
| Temporal association of sNfL and gad‐enhancing lesions in multiple sclerosis M Rosso, CT Gonzalez, BC Healy, S Saxena, A Paul, K Bjornevik, J Kuhle, ... Annals of clinical and translational neurology 7 (6), 945-955, 2020 | 37 | 2020 |
| Wilhelm Uhthoff and Uhthoff’s phenomenon A Jain, M Rosso, JD Santoro Multiple Sclerosis Journal 26 (13), 1790-1796, 2020 | 16 | 2020 |
| Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options M Rosso, S Saxena, T Chitnis Expert Review of Neurotherapeutics 20 (5), 509-516, 2020 | 16 | 2020 |
| MRI lesion state modulates the relationship between serum neurofilament light and age in multiple sclerosis M Rosso, BC Healy, S Saxena, A Paul, K Bjornevik, J Kuhle, P Benkert, ... Journal of Neuroimaging 31 (2), 388-393, 2021 | 10 | 2021 |
| Cross-sectional study of smoking exposure: no differential effect on OCT metrics in a cohort of MS patients M Rosso, DJ Kimbrough, CT Gonzalez, BI Glanz, BC Healy, MA Rocca, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 5 (1 …, 2019 | 9 | 2019 |
| Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS H Lokhande, M Rosso, S Tauhid, R Chu, BC Healy, S Saxena, C Barro, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 8 (1 …, 2022 | 8 | 2022 |
| Temporal trends of multiple sclerosis disease activity: Electronic health records indicators L Liang, N Kim, J Hou, T Cai, K Dahal, C Lin, S Finan, G Savovoa, ... Multiple sclerosis and related disorders 57, 103333, 2022 | 5 | 2022 |
| Gaetano Perusini: The forgotten neuroscientist behind “Alzheimer’s” disease F Pellegrini, M Rosso, DT Chu The Neuroscientist 29 (3), 273-276, 2023 | 3 | 2023 |
| Obesity is associated with the Optic Neuritis severity in Male patients with Multiple Sclerosis DT Chu, M Rosso, CT Gonzalez, S Saxena, BC Healy, HL Weiner, ... Multiple Sclerosis and Related Disorders 51, 102910, 2021 | 2 | 2021 |
| Longitudinal Study of Disease Burden and Complications in a Cohort of Multiple Sclerosis Patients over the Age of 65. M Rosso, CT Gonzalez, M Manieri, BC Healy, HL Weiner, T Chitnis ACTRIMS Forum 2019, 2019 | 2 | 2019 |
| Pliny the Elder: Lessons from the Naturalist as an Early Neuroscientist DT Chu, M Rosso, JD Santoro The Neuroscientist 29 (2), 150-157, 2023 | 1 | 2023 |
| Gaetano Perusini (1879–1915) M Rosso, D Chu Journal of Neurology 268 (11), 4400-4401, 2021 | 1 | 2021 |
| William Gordon Lennox (1884–1960) M Rosso, D Chu, JD Santoro Journal of Neurology, 1-2, 2021 | 1 | 2021 |
| Serum neurofilament light chain levels are increased within three months of new gadolinium enhancing lesions in multiple sclerosis M Rosso, C Gonzalez, B Healy, S Saxena, A Paul, K Bjornevik, ... MULTIPLE SCLEROSIS JOURNAL 25, 8-9, 2019 | 1 | 2019 |
| A20 (TNFAIP3) Distinguishes Relapse from Remission in Pediatric Patients with Monophasic MOGAD: Preliminary Results C Lechner, S Saxena, H Lokhande, M Breu, A Eisenkölbl, M Karenfort, ... Neuropediatrics 54 (S 01), A-140, 2023 | | 2023 |
| Ixekizumab-associated transverse myelopathy in a patient with psoriatic arthritis (P14-3.017) M Rosso, N Milano, E Gleichgerrcht Neurology 100 (17 Supplement 2), 2023 | | 2023 |
